thebench.bio #1 Ecosystem for the Bio-Tech Industry
All Pharmacovigilance questions

Question 4 of 6 Intermediate Concept

What evidence is useful in causality assessment?

Short answer

Causality assessment weighs timing, alternative explanations, dechallenge or rechallenge evidence, biological plausibility, dose relationship and previous evidence. No single feature usually proves drug causation.

Why

Suppose liver enzymes rise after starting a new medicine. Establish the sequence of exposure and injury, baseline tests, competing medicines, viral causes and underlying disease. Examine whether markers improve after withdrawal, while recognising spontaneous recovery or other treatments.

A recurrence after re-exposure can strengthen the association but deliberate rechallenge can be unsafe or unethical. Review known class effects, pharmacological mechanism and case quality. Document what evidence supports a suspicion and what remains unresolved, preferably using a consistent assessment approach for comparable cases.

A disproportionality signal or a positive temporal relationship is a reason to investigate, not a causal verdict. Likewise, an incomplete case may still warrant reporting when minimum criteria and jurisdictional requirements are met. Distinguish individual-case clinical assessment from population-level evidence such as epidemiological studies.

Common mistakes

  • Treating a positive dechallenge or a high reporting-odds ratio as conclusive proof